8CO announced a massive contract the day before that was a company maker and traded $3m worth of stock. They have multiple blue ribbon clients and operate with low costs. They are reporting record revenues and had $3m cash in the bank prior to the raise and in general have happy supportive shareholders due to quality investor communication.
Sensera is pretty illiquid, had under $1m cash and turned over $30k of stock the day prior, and has disgruntled shareholders who were selling the stock down everytime it started to move up. Even after the Abiomed announcement the stock was unable to sustain a run. Id be surprised if they got any interest if they priced it at 5% discount.
Apples and Oranges.
Add to My Watchlist
What is My Watchlist?